As of Feb 27
| 0.00 / 0.00%|
The 3 analysts offering 12-month price forecasts for Marrone Bio Innovations Inc have a median target of 2.50, with a high estimate of 3.50 and a low estimate of 2.00. The median estimate represents a +21.36% increase from the last price of 2.06.
The current consensus among 3 polled investment analysts is to Hold stock in Marrone Bio Innovations Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.